PRESS RELEASE published on 02/10/2026 at 18:00, 4 months 1 day ago THX Pharma and Biocodex announce a strategic licensing agreement covering three rare diseases Biocodex acquires licenses from THX Pharma to develop Batten-1 globally and TX01 in US and Canada. Deal worth up to €173M includes milestone payments and double-digit royalties Batten-1 Licenses TX01 THX Pharma Biocodex
BRIEF published on 01/27/2026 at 18:05, 4 months 15 days ago Theranexus Liquidity Contract Half-Year Review Liquidity Contract PORTZAMPARC Financial Report Theranexus THX Pharma Actions
BRIEF published on 01/20/2026 at 18:05, 4 months 22 days ago THX Pharma unveils its 2026 financial calendar Euronext Paris Financial Agenda Biopharmaceutical 2026 THX Pharma
BRIEF published on 01/20/2026 at 18:05, 4 months 22 days ago THX Pharma Reveals 2026 Financial Schedule Financial Calendar Neurological Diseases Market Communication 2026 Announcements THX Pharma
PRESS RELEASE published on 01/20/2026 at 18:00, 4 months 22 days ago THX Pharma Announces its 2026 Financial Calendar THX Pharma (Theranexus) announces financial communication agenda for 2026, focusing on rare neurological diseases treatments. Company listed on Euronext Growth Paris Euronext Growth Paris Financial Communication Theranexus Neurological Diseases THX Pharma
BRIEF published on 01/08/2026 at 18:05, 5 months 3 days ago Publication of the letter to shareholders by Theranexus Shareholders Neuroscience Rare Diseases Theranexus Drugs
BRIEF published on 01/08/2026 at 18:05, 5 months 3 days ago THX Pharma Releases Shareholder Letter Drug Development Biopharmaceutical Shareholder Communication Neurological Diseases THX Pharma
PRESS RELEASE published on 01/08/2026 at 18:00, 5 months 3 days ago THX Pharma announces the publication of its letter to shareholders THX Pharma (Theranexus) announces the publication of its letter to shareholders, highlighting treatments for rare neurological diseases and upcoming drug commercialization. Forward-looking statements included Forward-looking Statements Theranexus Neurological Diseases THX Pharma Drug Commercialization
BRIEF published on 01/07/2026 at 08:05, 5 months 5 days ago THX Pharma Names Julien Veys as Deputy CEO Rare Neurological Diseases THX Pharma Julien Veys Appointment Theranexus Strategy Pharmaceutical Commercialization
BRIEF published on 01/07/2026 at 08:05, 5 months 5 days ago THX Pharma appoints Julien Veys as Deputy General Manager Business Strategy Appointment THX Pharma Julien Veys Neurological Medications
Published on 06/12/2026 at 09:20, 2 hours 7 minutes ago CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) ASCO 2026 Key Highlights
Published on 06/12/2026 at 08:05, 3 hours 22 minutes ago Caledonia Mining Corporation Plc: Director/PDMR Shareholding Notification
Published on 06/12/2026 at 08:00, 3 hours 27 minutes ago Caledonia Mining Corporation Plc: Utilisation of the Block Admission in Respect of ATM Sales Agreement
Published on 06/12/2026 at 00:00, 11 hours 27 minutes ago Redwood AI Enters LOI to Explore Pathogen Tracking Through AI Genomics at the Border of Rwanda and the Democratic Republic of Congo with Aim of Potentially Tracing Ebola Virus Disease
Published on 06/12/2026 at 11:05, 22 minutes ago Apacer Launches GraTherX Thermal Solution, Reducing DDR5 Temperatures by Up to 23.4°C
Published on 06/12/2026 at 10:31, 56 minutes ago OHB and Helsing joint venture bridges the gap to start-ups – Alliance for Europe’s space sector takes shape
Published on 06/12/2026 at 10:29, 58 minutes ago EQS-Adhoc: KHD Humboldt Wedag International AG: KHD wins major contract in the USA
Published on 06/12/2026 at 10:00, 1 hour 27 minutes ago Kora Joins International Air Transport Association's (IATA) Payment Network to Power Airline Payments Across Africa
Published on 06/12/2026 at 09:35, 1 hour 52 minutes ago Simcere Pharmaceutical Enters into a Research Collaboration Agreement with Stanford Medicine to Develop Innovative Therapies for Patients with Idiopathic Pulmonary Fibrosis
Published on 06/12/2026 at 09:00, 2 hours 27 minutes ago Pricing of Green Senior Secured Notes due 2031 by Neoen FINCO PLC
Published on 06/11/2026 at 17:45, 17 hours 42 minutes ago BAIKOWSKI: Annual General Meeting of June 11, 2026 - Dividend of €0.30 per share, to be paid out on June 30, 2026
Published on 06/11/2026 at 08:45, 1 day 2 hours ago Air Liquide and ArianeGroup renew strategic industrial partnership with two major Ariane 6 contracts
